172 related articles for article (PubMed ID: 30191889)
1. Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy.
Kang S; Hong YL; Ku BC; Lee S; Ryu S; Min DH; Jang H; Kim YK
Nanotechnology; 2018 Nov; 29(47):475604. PubMed ID: 30191889
[TBL] [Abstract][Full Text] [Related]
2. Reduced graphene oxide coated Cu
Zhen SJ; Wang TT; Liu YX; Wu ZL; Zou HY; Huang CZ
J Photochem Photobiol B; 2018 Mar; 180():9-16. PubMed ID: 29413707
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine-doped virus-like mesoporous silica coated reduced graphene oxide nanosheets for chemo-photothermal synergetic therapy.
Liao J; Zhang H; Wang X
J Biomater Appl; 2020 Jul; 35(1):28-38. PubMed ID: 32279577
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine doped reduced graphene oxide/mesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy.
Liu R; Zhang H; Zhang F; Wang X; Liu X; Zhang Y
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():138-145. PubMed ID: 30606519
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
6. Nanocomposite plasters for the treatment of superficial tumors by chemo-photothermal combination therapy.
Qi W; Yan J; Sun H; Wang H
Int J Nanomedicine; 2018; 13():6235-6247. PubMed ID: 30349247
[TBL] [Abstract][Full Text] [Related]
7. One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy.
Hu Y; He L; Ding J; Sun D; Chen L; Chen X
Carbohydr Polym; 2016 Jun; 144():223-9. PubMed ID: 27083812
[TBL] [Abstract][Full Text] [Related]
8. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
Liu W; Zhang X; Zhou L; Shang L; Su Z
J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
[TBL] [Abstract][Full Text] [Related]
9. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-functionalized nanographene oxide: a versatile nanocarrier for chemotherapy and photothermal therapy.
Zhang X; Nan X; Shi W; Sun Y; Su H; He Y; Liu X; Zhang Z; Ge D
Nanotechnology; 2017 Jul; 28(29):295102. PubMed ID: 28656906
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
12. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy.
Qiang L; Cai Z; Jiang W; Liu J; Tai Z; Li G; Gong C; Gao S; Gao Y
J Nanobiotechnology; 2019 Jul; 17(1):83. PubMed ID: 31291948
[TBL] [Abstract][Full Text] [Related]
13. Efficient combined near-infrared-triggered therapy: Phototherapy over chemotherapy in chitosan-reduced graphene oxide-IR820 dye-doxorubicin nanoplatforms.
Zaharie-Butucel D; Potara M; Suarasan S; Licarete E; Astilean S
J Colloid Interface Sci; 2019 Sep; 552():218-229. PubMed ID: 31128402
[TBL] [Abstract][Full Text] [Related]
14. Poly(allylamine hydrochloride)-functionalized reduced graphene oxide for synergistic chemo-photothermal therapy.
Roy S; Sarkar A; Jaiswal A
Nanomedicine (Lond); 2019 Feb; 14(3):255-274. PubMed ID: 30676277
[TBL] [Abstract][Full Text] [Related]
15. Direct generation of Ag nanoclusters on reduced graphene oxide nanosheets for efficient catalysis, antibacteria and photothermal anticancer applications.
Li M; Huang L; Wang X; Song Z; Zhao W; Wang Y; Liu J
J Colloid Interface Sci; 2018 Nov; 529():444-451. PubMed ID: 30078416
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
17. Development of a Graphene Oxide Nanocarrier for Dual-Drug Chemo-phototherapy to Overcome Drug Resistance in Cancer.
Tran TH; Nguyen HT; Pham TT; Choi JY; Choi HG; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28647-55. PubMed ID: 26641922
[TBL] [Abstract][Full Text] [Related]
18. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
Kim H; Lee D; Kim J; Kim TI; Kim WJ
ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy.
Qin XC; Guo ZY; Liu ZM; Zhang W; Wan MM; Yang BW
J Photochem Photobiol B; 2013 Mar; 120():156-62. PubMed ID: 23357205
[TBL] [Abstract][Full Text] [Related]
20. One-step synthesis of soy protein/graphene nanocomposites and their application in photothermal therapy.
Jiang X; Li Z; Yao J; Shao Z; Chen X
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():798-804. PubMed ID: 27524082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
